id	sid	tid	token	lemma	pos
cord-344478-5gp7v1uh	1	1	key	key	NN
cord-344478-5gp7v1uh	1	2	:	:	:
cord-344478-5gp7v1uh	2	1	cord-344478	cord-344478	NNP
cord-344478-5gp7v1uh	2	2	-	-	HYPH
cord-344478-5gp7v1uh	2	3	5gp7v1uh	5gp7v1uh	CD
cord-344478-5gp7v1uh	2	4	authors	author	NNS
cord-344478-5gp7v1uh	2	5	:	:	:
cord-344478-5gp7v1uh	2	6	Rosenberg	Rosenberg	NNP
cord-344478-5gp7v1uh	2	7	,	,	,
cord-344478-5gp7v1uh	2	8	Eli	Eli	NNP
cord-344478-5gp7v1uh	2	9	S.	S.	NNP
cord-344478-5gp7v1uh	2	10	;	;	:
cord-344478-5gp7v1uh	2	11	Holtgrave	Holtgrave	NNP
cord-344478-5gp7v1uh	2	12	,	,	,
cord-344478-5gp7v1uh	2	13	David	David	NNP
cord-344478-5gp7v1uh	2	14	R.	R.	NNP
cord-344478-5gp7v1uh	2	15	;	;	:
cord-344478-5gp7v1uh	2	16	Udo	Udo	NNP
cord-344478-5gp7v1uh	2	17	,	,	,
cord-344478-5gp7v1uh	2	18	Tomoko	Tomoko	NNP
cord-344478-5gp7v1uh	2	19	title	title	NN
cord-344478-5gp7v1uh	2	20	:	:	:
cord-344478-5gp7v1uh	2	21	Clarifying	clarify	VBG
cord-344478-5gp7v1uh	2	22	the	the	DT
cord-344478-5gp7v1uh	2	23	record	record	NN
cord-344478-5gp7v1uh	2	24	on	on	IN
cord-344478-5gp7v1uh	2	25	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	2	26	for	for	IN
cord-344478-5gp7v1uh	2	27	the	the	DT
cord-344478-5gp7v1uh	2	28	treatment	treatment	NN
cord-344478-5gp7v1uh	2	29	of	of	IN
cord-344478-5gp7v1uh	2	30	patients	patient	NNS
cord-344478-5gp7v1uh	2	31	hospitalized	hospitalize	VBN
cord-344478-5gp7v1uh	2	32	with	with	IN
cord-344478-5gp7v1uh	2	33	COVID-19	covid-19	CD
cord-344478-5gp7v1uh	2	34	date	date	NN
cord-344478-5gp7v1uh	2	35	:	:	:
cord-344478-5gp7v1uh	2	36	2020	2020	CD
cord-344478-5gp7v1uh	2	37	-	-	HYPH
cord-344478-5gp7v1uh	2	38	07	07	CD
cord-344478-5gp7v1uh	2	39	-	-	HYPH
cord-344478-5gp7v1uh	2	40	29	29	CD
cord-344478-5gp7v1uh	2	41	journal	journal	NN
cord-344478-5gp7v1uh	2	42	:	:	:
cord-344478-5gp7v1uh	3	1	Int	Int	NNP
cord-344478-5gp7v1uh	3	2	J	J	NNP
cord-344478-5gp7v1uh	3	3	Infect	infect	VB
cord-344478-5gp7v1uh	3	4	Dis	Dis	NNP
cord-344478-5gp7v1uh	3	5	DOI	doi	NN
cord-344478-5gp7v1uh	3	6	:	:	:
cord-344478-5gp7v1uh	3	7	10.1016/	10.1016/	CD
cord-344478-5gp7v1uh	4	1	j.ijid.2020.07.055	j.ijid.2020.07.055	NNP
cord-344478-5gp7v1uh	5	1	sha	sha	NNP
cord-344478-5gp7v1uh	5	2	:	:	:
cord-344478-5gp7v1uh	6	1	fc420740c1641337c46203b4d250fb17a9fcab17	fc420740c1641337c46203b4d250fb17a9fcab17	RB
cord-344478-5gp7v1uh	6	2	doc_id	doc_id	CD
cord-344478-5gp7v1uh	6	3	:	:	:
cord-344478-5gp7v1uh	6	4	344478	344478	CD
cord-344478-5gp7v1uh	6	5	cord_uid	cord_uid	NNS
cord-344478-5gp7v1uh	6	6	:	:	:
cord-344478-5gp7v1uh	7	1	5gp7v1uh	5gp7v1uh	CD
cord-344478-5gp7v1uh	7	2	nan	nan	NNP
cord-344478-5gp7v1uh	8	1	To	to	IN
cord-344478-5gp7v1uh	8	2	the	the	DT
cord-344478-5gp7v1uh	8	3	editors	editor	NNS
cord-344478-5gp7v1uh	8	4	,	,	,
cord-344478-5gp7v1uh	8	5	The	the	DT
cord-344478-5gp7v1uh	8	6	study	study	NN
cord-344478-5gp7v1uh	8	7	from	from	IN
cord-344478-5gp7v1uh	8	8	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	8	9	et	et	NNP
cord-344478-5gp7v1uh	8	10	al	al	NNP
cord-344478-5gp7v1uh	8	11	on	on	IN
cord-344478-5gp7v1uh	8	12	the	the	DT
cord-344478-5gp7v1uh	8	13	use	use	NN
cord-344478-5gp7v1uh	8	14	of	of	IN
cord-344478-5gp7v1uh	8	15	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	8	16	,	,	,
cord-344478-5gp7v1uh	8	17	with	with	IN
cord-344478-5gp7v1uh	8	18	and	and	CC
cord-344478-5gp7v1uh	8	19	without	without	IN
cord-344478-5gp7v1uh	8	20	azithromycin	azithromycin	NNP
cord-344478-5gp7v1uh	8	21	,	,	,
cord-344478-5gp7v1uh	8	22	for	for	IN
cord-344478-5gp7v1uh	8	23	the	the	DT
cord-344478-5gp7v1uh	8	24	treatment	treatment	NN
cord-344478-5gp7v1uh	8	25	of	of	IN
cord-344478-5gp7v1uh	8	26	inpatients	inpatient	NNS
cord-344478-5gp7v1uh	8	27	with	with	IN
cord-344478-5gp7v1uh	8	28	COVID-19	covid-19	CD
cord-344478-5gp7v1uh	8	29	in	in	IN
cord-344478-5gp7v1uh	8	30	one	one	CD
cord-344478-5gp7v1uh	8	31	healthcare	healthcare	NN
cord-344478-5gp7v1uh	8	32	system	system	NN
cord-344478-5gp7v1uh	8	33	(	(	-LRB-
cord-344478-5gp7v1uh	8	34	Henry	Henry	NNP
cord-344478-5gp7v1uh	8	35	Ford	Ford	NNP
cord-344478-5gp7v1uh	8	36	Health	Health	NNP
cord-344478-5gp7v1uh	8	37	System	System	NNP
cord-344478-5gp7v1uh	8	38	)	)	-RRB-
cord-344478-5gp7v1uh	8	39	is	be	VBZ
cord-344478-5gp7v1uh	8	40	a	a	DT
cord-344478-5gp7v1uh	8	41	new	new	JJ
cord-344478-5gp7v1uh	8	42	entrant	entrant	NN
cord-344478-5gp7v1uh	8	43	into	into	IN
cord-344478-5gp7v1uh	8	44	the	the	DT
cord-344478-5gp7v1uh	8	45	rapidly	rapidly	RB
cord-344478-5gp7v1uh	8	46	expanding	expand	VBG
cord-344478-5gp7v1uh	8	47	literature	literature	NN
cord-344478-5gp7v1uh	8	48	on	on	IN
cord-344478-5gp7v1uh	8	49	the	the	DT
cord-344478-5gp7v1uh	8	50	treatment	treatment	NN
cord-344478-5gp7v1uh	8	51	of	of	IN
cord-344478-5gp7v1uh	8	52	this	this	DT
cord-344478-5gp7v1uh	8	53	disease	disease	NN
cord-344478-5gp7v1uh	8	54	[	[	-LRB-
cord-344478-5gp7v1uh	8	55	1	1	CD
cord-344478-5gp7v1uh	8	56	,	,	,
cord-344478-5gp7v1uh	8	57	2	2	CD
cord-344478-5gp7v1uh	8	58	]	]	-RRB-
cord-344478-5gp7v1uh	8	59	.	.	.
cord-344478-5gp7v1uh	9	1	The	the	DT
cord-344478-5gp7v1uh	9	2	study	study	NN
cord-344478-5gp7v1uh	9	3	's	's	POS
cord-344478-5gp7v1uh	9	4	findings	finding	NNS
cord-344478-5gp7v1uh	9	5	of	of	IN
cord-344478-5gp7v1uh	9	6	a	a	DT
cord-344478-5gp7v1uh	9	7	significant	significant	JJ
cord-344478-5gp7v1uh	9	8	beneficial	beneficial	JJ
cord-344478-5gp7v1uh	9	9	effect	effect	NN
cord-344478-5gp7v1uh	9	10	of	of	IN
cord-344478-5gp7v1uh	9	11	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	9	12	in	in	IN
cord-344478-5gp7v1uh	9	13	the	the	DT
cord-344478-5gp7v1uh	9	14	reduction	reduction	NN
cord-344478-5gp7v1uh	9	15	of	of	IN
cord-344478-5gp7v1uh	9	16	in	in	IN
cord-344478-5gp7v1uh	9	17	-	-	HYPH
cord-344478-5gp7v1uh	9	18	hospital	hospital	NN
cord-344478-5gp7v1uh	9	19	mortality	mortality	NN
cord-344478-5gp7v1uh	9	20	are	be	VBP
cord-344478-5gp7v1uh	9	21	not	not	RB
cord-344478-5gp7v1uh	9	22	consistent	consistent	JJ
cord-344478-5gp7v1uh	9	23	with	with	IN
cord-344478-5gp7v1uh	9	24	several	several	JJ
cord-344478-5gp7v1uh	9	25	recent	recent	JJ
cord-344478-5gp7v1uh	9	26	studies	study	NNS
cord-344478-5gp7v1uh	9	27	and	and	CC
cord-344478-5gp7v1uh	9	28	as	as	IN
cord-344478-5gp7v1uh	9	29	authors	author	NNS
cord-344478-5gp7v1uh	9	30	of	of	IN
cord-344478-5gp7v1uh	9	31	one	one	CD
cord-344478-5gp7v1uh	9	32	of	of	IN
cord-344478-5gp7v1uh	9	33	those	those	DT
cord-344478-5gp7v1uh	9	34	studies	study	NNS
cord-344478-5gp7v1uh	9	35	we	-PRON-	PRP
cord-344478-5gp7v1uh	9	36	wish	wish	VBP
cord-344478-5gp7v1uh	9	37	to	to	TO
cord-344478-5gp7v1uh	9	38	share	share	VB
cord-344478-5gp7v1uh	9	39	a	a	DT
cord-344478-5gp7v1uh	9	40	few	few	JJ
cord-344478-5gp7v1uh	9	41	observations	observation	NNS
cord-344478-5gp7v1uh	9	42	[	[	-LRB-
cord-344478-5gp7v1uh	9	43	2	2	CD
cord-344478-5gp7v1uh	9	44	]	]	-RRB-
cord-344478-5gp7v1uh	9	45	[	[	-LRB-
cord-344478-5gp7v1uh	9	46	3	3	CD
cord-344478-5gp7v1uh	9	47	]	]	-RRB-
cord-344478-5gp7v1uh	9	48	[	[	-LRB-
cord-344478-5gp7v1uh	9	49	4	4	CD
cord-344478-5gp7v1uh	9	50	]	]	-RRB-
cord-344478-5gp7v1uh	9	51	.	.	.
cord-344478-5gp7v1uh	10	1	In	in	IN
cord-344478-5gp7v1uh	10	2	the	the	DT
cord-344478-5gp7v1uh	10	3	Discussion	Discussion	NNP
cord-344478-5gp7v1uh	10	4	section	section	NN
cord-344478-5gp7v1uh	10	5	,	,	,
cord-344478-5gp7v1uh	10	6	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	10	7	et	et	NNP
cord-344478-5gp7v1uh	10	8	al	al	NNP
cord-344478-5gp7v1uh	10	9	distinguish	distinguish	VB
cord-344478-5gp7v1uh	10	10	their	-PRON-	PRP$
cord-344478-5gp7v1uh	10	11	study	study	NN
cord-344478-5gp7v1uh	10	12	from	from	IN
cord-344478-5gp7v1uh	10	13	our	-PRON-	PRP$
cord-344478-5gp7v1uh	10	14	cohort	cohort	NN
cord-344478-5gp7v1uh	10	15	study	study	NN
cord-344478-5gp7v1uh	10	16	of	of	IN
cord-344478-5gp7v1uh	10	17	1,438	1,438	CD
cord-344478-5gp7v1uh	10	18	patients	patient	NNS
cord-344478-5gp7v1uh	10	19	in	in	IN
cord-344478-5gp7v1uh	10	20	25	25	CD
cord-344478-5gp7v1uh	10	21	New	New	NNP
cord-344478-5gp7v1uh	10	22	York	York	NNP
cord-344478-5gp7v1uh	10	23	metropolitan	metropolitan	JJ
cord-344478-5gp7v1uh	10	24	region	region	NN
cord-344478-5gp7v1uh	10	25	hospitals	hospital	NNS
cord-344478-5gp7v1uh	10	26	,	,	,
cord-344478-5gp7v1uh	10	27	which	which	WDT
cord-344478-5gp7v1uh	10	28	found	find	VBD
cord-344478-5gp7v1uh	10	29	a	a	DT
cord-344478-5gp7v1uh	10	30	generally	generally	RB
cord-344478-5gp7v1uh	10	31	null	null	JJ
cord-344478-5gp7v1uh	10	32	association	association	NN
cord-344478-5gp7v1uh	10	33	between	between	IN
cord-344478-5gp7v1uh	10	34	these	these	DT
cord-344478-5gp7v1uh	10	35	medications	medication	NNS
cord-344478-5gp7v1uh	10	36	and	and	CC
cord-344478-5gp7v1uh	10	37	mortality	mortality	NN
cord-344478-5gp7v1uh	10	38	[	[	-LRB-
cord-344478-5gp7v1uh	10	39	1	1	CD
cord-344478-5gp7v1uh	10	40	,	,	,
cord-344478-5gp7v1uh	10	41	4	4	CD
cord-344478-5gp7v1uh	10	42	]	]	-RRB-
cord-344478-5gp7v1uh	10	43	.	.	.
cord-344478-5gp7v1uh	11	1	In	in	IN
cord-344478-5gp7v1uh	11	2	doing	do	VBG
cord-344478-5gp7v1uh	11	3	so	so	RB
cord-344478-5gp7v1uh	11	4	,	,	,
cord-344478-5gp7v1uh	11	5	the	the	DT
cord-344478-5gp7v1uh	11	6	authors	author	NNS
cord-344478-5gp7v1uh	11	7	make	make	VBP
cord-344478-5gp7v1uh	11	8	multiple	multiple	JJ
cord-344478-5gp7v1uh	11	9	statements	statement	NNS
cord-344478-5gp7v1uh	11	10	that	that	WDT
cord-344478-5gp7v1uh	11	11	are	be	VBP
cord-344478-5gp7v1uh	11	12	not	not	RB
cord-344478-5gp7v1uh	11	13	factually	factually	RB
cord-344478-5gp7v1uh	11	14	aligned	align	VBN
cord-344478-5gp7v1uh	11	15	with	with	IN
cord-344478-5gp7v1uh	11	16	our	-PRON-	PRP$
cord-344478-5gp7v1uh	11	17	published	published	JJ
cord-344478-5gp7v1uh	11	18	research	research	NN
cord-344478-5gp7v1uh	11	19	.	.	.
cord-344478-5gp7v1uh	12	1	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	12	2	et	et	NNP
cord-344478-5gp7v1uh	12	3	al	al	NNP
cord-344478-5gp7v1uh	12	4	state	state	NN
cord-344478-5gp7v1uh	12	5	that	that	IN
cord-344478-5gp7v1uh	12	6	the	the	DT
cord-344478-5gp7v1uh	12	7	Rosenberg	Rosenberg	NNP
cord-344478-5gp7v1uh	12	8	et	et	NNP
cord-344478-5gp7v1uh	12	9	al	al	NNP
cord-344478-5gp7v1uh	12	10	"	"	''
cord-344478-5gp7v1uh	12	11	…	…	NFP
cord-344478-5gp7v1uh	12	12	study	study	NN
cord-344478-5gp7v1uh	12	13	included	include	VBD
cord-344478-5gp7v1uh	12	14	patients	patient	NNS
cord-344478-5gp7v1uh	12	15	who	who	WP
cord-344478-5gp7v1uh	12	16	were	be	VBD
cord-344478-5gp7v1uh	12	17	initiated	initiate	VBN
cord-344478-5gp7v1uh	12	18	on	on	IN
cord-344478-5gp7v1uh	12	19	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	12	20	therapy	therapy	NN
cord-344478-5gp7v1uh	12	21	at	at	IN
cord-344478-5gp7v1uh	12	22	any	any	DT
cord-344478-5gp7v1uh	12	23	time	time	NN
cord-344478-5gp7v1uh	12	24	during	during	IN
cord-344478-5gp7v1uh	12	25	their	-PRON-	PRP$
cord-344478-5gp7v1uh	12	26	hospitalization	hospitalization	NN
cord-344478-5gp7v1uh	12	27	.	.	.
cord-344478-5gp7v1uh	13	1	In	in	IN
cord-344478-5gp7v1uh	13	2	contrast	contrast	NN
cord-344478-5gp7v1uh	13	3	,	,	,
cord-344478-5gp7v1uh	13	4	in	in	IN
cord-344478-5gp7v1uh	13	5	our	-PRON-	PRP$
cord-344478-5gp7v1uh	13	6	patient	patient	JJ
cord-344478-5gp7v1uh	13	7	population	population	NN
cord-344478-5gp7v1uh	13	8	,	,	,
cord-344478-5gp7v1uh	13	9	82	82	CD
cord-344478-5gp7v1uh	13	10	%	%	NN
cord-344478-5gp7v1uh	13	11	received	receive	VBD
cord-344478-5gp7v1uh	13	12	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	13	13	within	within	IN
cord-344478-5gp7v1uh	13	14	the	the	DT
cord-344478-5gp7v1uh	13	15	first	first	JJ
cord-344478-5gp7v1uh	13	16	24	24	CD
cord-344478-5gp7v1uh	13	17	hours	hour	NNS
cord-344478-5gp7v1uh	13	18	of	of	IN
cord-344478-5gp7v1uh	13	19	admission	admission	NN
cord-344478-5gp7v1uh	13	20	,	,	,
cord-344478-5gp7v1uh	13	21	and	and	CC
cord-344478-5gp7v1uh	13	22	91	91	CD
cord-344478-5gp7v1uh	13	23	%	%	NN
cord-344478-5gp7v1uh	13	24	within	within	IN
cord-344478-5gp7v1uh	13	25	48	48	CD
cord-344478-5gp7v1uh	13	26	hours	hour	NNS
cord-344478-5gp7v1uh	13	27	of	of	IN
cord-344478-5gp7v1uh	13	28	admission	admission	NN
cord-344478-5gp7v1uh	13	29	.	.	.
cord-344478-5gp7v1uh	13	30	"	"	''
cord-344478-5gp7v1uh	14	1	[	[	-LRB-
cord-344478-5gp7v1uh	14	2	1	1	CD
cord-344478-5gp7v1uh	14	3	]	]	-RRB-
cord-344478-5gp7v1uh	14	4	.	.	.
cord-344478-5gp7v1uh	15	1	Although	although	IN
cord-344478-5gp7v1uh	15	2	we	-PRON-	PRP
cord-344478-5gp7v1uh	15	3	included	include	VBD
cord-344478-5gp7v1uh	15	4	those	those	DT
cord-344478-5gp7v1uh	15	5	who	who	WP
cord-344478-5gp7v1uh	15	6	received	receive	VBD
cord-344478-5gp7v1uh	15	7	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	15	8	or	or	CC
cord-344478-5gp7v1uh	15	9	azithromycin	azithromycin	NNP
cord-344478-5gp7v1uh	15	10	at	at	IN
cord-344478-5gp7v1uh	15	11	any	any	DT
cord-344478-5gp7v1uh	15	12	time	time	NN
cord-344478-5gp7v1uh	15	13	during	during	IN
cord-344478-5gp7v1uh	15	14	hospitalization	hospitalization	NN
cord-344478-5gp7v1uh	15	15	,	,	,
cord-344478-5gp7v1uh	15	16	we	-PRON-	PRP
cord-344478-5gp7v1uh	15	17	reported	report	VBD
cord-344478-5gp7v1uh	15	18	detailed	detailed	JJ
cord-344478-5gp7v1uh	15	19	information	information	NN
cord-344478-5gp7v1uh	15	20	on	on	IN
cord-344478-5gp7v1uh	15	21	length	length	NN
cord-344478-5gp7v1uh	15	22	of	of	IN
cord-344478-5gp7v1uh	15	23	time	time	NN
cord-344478-5gp7v1uh	15	24	from	from	IN
cord-344478-5gp7v1uh	15	25	admission	admission	NN
cord-344478-5gp7v1uh	15	26	to	to	IN
cord-344478-5gp7v1uh	15	27	initiation	initiation	NN
cord-344478-5gp7v1uh	15	28	of	of	IN
cord-344478-5gp7v1uh	15	29	either	either	DT
cord-344478-5gp7v1uh	15	30	therapy	therapy	NN
cord-344478-5gp7v1uh	15	31	(	(	-LRB-
cord-344478-5gp7v1uh	15	32	as	as	RB
cord-344478-5gp7v1uh	15	33	well	well	RB
cord-344478-5gp7v1uh	15	34	as	as	IN
cord-344478-5gp7v1uh	15	35	on	on	IN
cord-344478-5gp7v1uh	15	36	dosage	dosage	NN
cord-344478-5gp7v1uh	15	37	patterns	pattern	NNS
cord-344478-5gp7v1uh	15	38	)	)	-RRB-
cord-344478-5gp7v1uh	15	39	.	.	.
cord-344478-5gp7v1uh	16	1	In	in	IN
cord-344478-5gp7v1uh	16	2	fact	fact	NN
cord-344478-5gp7v1uh	16	3	,	,	,
cord-344478-5gp7v1uh	16	4	patients	patient	NNS
cord-344478-5gp7v1uh	16	5	in	in	IN
cord-344478-5gp7v1uh	16	6	our	-PRON-	PRP$
cord-344478-5gp7v1uh	16	7	study	study	NN
cord-344478-5gp7v1uh	16	8	had	have	VBD
cord-344478-5gp7v1uh	16	9	been	be	VBN
cord-344478-5gp7v1uh	16	10	generally	generally	RB
cord-344478-5gp7v1uh	16	11	initiated	initiate	VBN
cord-344478-5gp7v1uh	16	12	rapidly	rapidly	RB
cord-344478-5gp7v1uh	16	13	:	:	:
cord-344478-5gp7v1uh	16	14	"	"	``
cord-344478-5gp7v1uh	16	15	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	16	16	was	be	VBD
cord-344478-5gp7v1uh	16	17	initiated	initiate	VBN
cord-344478-5gp7v1uh	16	18	at	at	IN
cord-344478-5gp7v1uh	16	19	a	a	DT
cord-344478-5gp7v1uh	16	20	median	median	NN
cord-344478-5gp7v1uh	16	21	of	of	IN
cord-344478-5gp7v1uh	16	22	1	1	CD
cord-344478-5gp7v1uh	16	23	day	day	NN
cord-344478-5gp7v1uh	16	24	(	(	-LRB-
cord-344478-5gp7v1uh	16	25	Q1-Q3	Q1-Q3	NNP
cord-344478-5gp7v1uh	16	26	,	,	,
cord-344478-5gp7v1uh	16	27	1	1	CD
cord-344478-5gp7v1uh	16	28	-	-	SYM
cord-344478-5gp7v1uh	16	29	2	2	CD
cord-344478-5gp7v1uh	16	30	)	)	-RRB-
cord-344478-5gp7v1uh	16	31	following	follow	VBG
cord-344478-5gp7v1uh	16	32	admission	admission	NN
cord-344478-5gp7v1uh	16	33	and	and	CC
cord-344478-5gp7v1uh	16	34	azithromycin	azithromycin	NN
cord-344478-5gp7v1uh	16	35	was	be	VBD
cord-344478-5gp7v1uh	16	36	given	give	VBN
cord-344478-5gp7v1uh	16	37	at	at	IN
cord-344478-5gp7v1uh	16	38	a	a	DT
cord-344478-5gp7v1uh	16	39	median	median	NN
cord-344478-5gp7v1uh	16	40	of	of	IN
cord-344478-5gp7v1uh	16	41	0	0	CD
cord-344478-5gp7v1uh	16	42	days	day	NNS
cord-344478-5gp7v1uh	16	43	(	(	-LRB-
cord-344478-5gp7v1uh	16	44	Q1-Q3	Q1-Q3	NNP
cord-344478-5gp7v1uh	16	45	,	,	,
cord-344478-5gp7v1uh	16	46	0	0	CD
cord-344478-5gp7v1uh	16	47	-	-	SYM
cord-344478-5gp7v1uh	16	48	1	1	CD
cord-344478-5gp7v1uh	16	49	)	)	-RRB-
cord-344478-5gp7v1uh	16	50	.	.	.
cord-344478-5gp7v1uh	16	51	"	"	''
cord-344478-5gp7v1uh	17	1	[	[	-LRB-
cord-344478-5gp7v1uh	17	2	4	4	CD
cord-344478-5gp7v1uh	17	3	]	]	-RRB-
cord-344478-5gp7v1uh	17	4	.	.	.
cord-344478-5gp7v1uh	18	1	This	this	DT
cord-344478-5gp7v1uh	18	2	distribution	distribution	NN
cord-344478-5gp7v1uh	18	3	is	be	VBZ
cord-344478-5gp7v1uh	18	4	quite	quite	RB
cord-344478-5gp7v1uh	18	5	similar	similar	JJ
cord-344478-5gp7v1uh	18	6	to	to	IN
cord-344478-5gp7v1uh	18	7	that	that	DT
cord-344478-5gp7v1uh	18	8	of	of	IN
cord-344478-5gp7v1uh	18	9	the	the	DT
cord-344478-5gp7v1uh	18	10	Henry	Henry	NNP
cord-344478-5gp7v1uh	18	11	Ford	Ford	NNP
cord-344478-5gp7v1uh	18	12	study	study	NN
cord-344478-5gp7v1uh	18	13	.	.	.
cord-344478-5gp7v1uh	19	1	The	the	DT
cord-344478-5gp7v1uh	19	2	authors	author	NNS
cord-344478-5gp7v1uh	19	3	next	next	IN
cord-344478-5gp7v1uh	19	4	state	state	NN
cord-344478-5gp7v1uh	19	5	the	the	DT
cord-344478-5gp7v1uh	19	6	following	follow	VBG
cord-344478-5gp7v1uh	19	7	about	about	IN
cord-344478-5gp7v1uh	19	8	our	-PRON-	PRP$
cord-344478-5gp7v1uh	19	9	work	work	NN
cord-344478-5gp7v1uh	19	10	:	:	:
cord-344478-5gp7v1uh	19	11	"	"	``
cord-344478-5gp7v1uh	19	12	Because	because	IN
cord-344478-5gp7v1uh	19	13	treatment	treatment	NN
cord-344478-5gp7v1uh	19	14	regimens	regimen	NNS
cord-344478-5gp7v1uh	19	15	likely	likely	RB
cord-344478-5gp7v1uh	19	16	varied	varied	JJ
cord-344478-5gp7v1uh	19	17	substantially	substantially	RB
cord-344478-5gp7v1uh	19	18	(	(	-LRB-
cord-344478-5gp7v1uh	19	19	including	include	VBG
cord-344478-5gp7v1uh	19	20	delayed	delay	VBN
cord-344478-5gp7v1uh	19	21	initiation	initiation	NN
cord-344478-5gp7v1uh	19	22	)	)	-RRB-
cord-344478-5gp7v1uh	19	23	across	across	IN
cord-344478-5gp7v1uh	19	24	the	the	DT
cord-344478-5gp7v1uh	19	25	25	25	CD
cord-344478-5gp7v1uh	19	26	hospitals	hospital	NNS
cord-344478-5gp7v1uh	19	27	that	that	WDT
cord-344478-5gp7v1uh	19	28	contributed	contribute	VBD
cord-344478-5gp7v1uh	19	29	patients	patient	NNS
cord-344478-5gp7v1uh	19	30	to	to	IN
cord-344478-5gp7v1uh	19	31	the	the	DT
cord-344478-5gp7v1uh	19	32	study	study	NN
cord-344478-5gp7v1uh	19	33	,	,	,
cord-344478-5gp7v1uh	19	34	it	-PRON-	PRP
cord-344478-5gp7v1uh	19	35	is	be	VBZ
cord-344478-5gp7v1uh	19	36	not	not	RB
cord-344478-5gp7v1uh	19	37	surprising	surprising	JJ
cord-344478-5gp7v1uh	19	38	that	that	IN
cord-344478-5gp7v1uh	19	39	the	the	DT
cord-344478-5gp7v1uh	19	40	case	case	NN
cord-344478-5gp7v1uh	19	41	-	-	HYPH
cord-344478-5gp7v1uh	19	42	fatality	fatality	NN
cord-344478-5gp7v1uh	19	43	rate	rate	NN
cord-344478-5gp7v1uh	19	44	among	among	IN
cord-344478-5gp7v1uh	19	45	the	the	DT
cord-344478-5gp7v1uh	19	46	New	New	NNP
cord-344478-5gp7v1uh	19	47	York	York	NNP
cord-344478-5gp7v1uh	19	48	patients	patient	NNS
cord-344478-5gp7v1uh	19	49	was	be	VBD
cord-344478-5gp7v1uh	19	50	significantly	significantly	RB
cord-344478-5gp7v1uh	19	51	higher	high	JJR
cord-344478-5gp7v1uh	19	52	than	than	IN
cord-344478-5gp7v1uh	19	53	J	J	NNP
cord-344478-5gp7v1uh	19	54	o	o	NN
cord-344478-5gp7v1uh	19	55	u	u	NN
cord-344478-5gp7v1uh	19	56	r	r	NN
cord-344478-5gp7v1uh	19	57	n	n	NN
cord-344478-5gp7v1uh	19	58	a	a	DT
cord-344478-5gp7v1uh	19	59	l	l	NN
cord-344478-5gp7v1uh	19	60	P	p	NN
cord-344478-5gp7v1uh	19	61	r	r	NN
cord-344478-5gp7v1uh	19	62	e	e	NN
cord-344478-5gp7v1uh	19	63	-p	-p	NN
cord-344478-5gp7v1uh	19	64	r	r	NN
cord-344478-5gp7v1uh	19	65	o	o	NN
cord-344478-5gp7v1uh	19	66	o	o	NN
cord-344478-5gp7v1uh	19	67	f	f	NN
cord-344478-5gp7v1uh	19	68	in	in	IN
cord-344478-5gp7v1uh	19	69	our	-PRON-	PRP$
cord-344478-5gp7v1uh	19	70	study	study	NN
cord-344478-5gp7v1uh	19	71	.	.	.
cord-344478-5gp7v1uh	20	1	"	"	''
cord-344478-5gp7v1uh	21	1	This	this	DT
cord-344478-5gp7v1uh	21	2	statement	statement	NN
cord-344478-5gp7v1uh	21	3	neglects	neglect	VBZ
cord-344478-5gp7v1uh	21	4	the	the	DT
cord-344478-5gp7v1uh	21	5	extensive	extensive	JJ
cord-344478-5gp7v1uh	21	6	statistical	statistical	JJ
cord-344478-5gp7v1uh	21	7	adjustment	adjustment	NN
cord-344478-5gp7v1uh	21	8	for	for	IN
cord-344478-5gp7v1uh	21	9	between	between	IN
cord-344478-5gp7v1uh	21	10	-	-	HYPH
cord-344478-5gp7v1uh	21	11	facility	facility	NN
cord-344478-5gp7v1uh	21	12	variation	variation	NN
cord-344478-5gp7v1uh	21	13	in	in	IN
cord-344478-5gp7v1uh	21	14	our	-PRON-	PRP$
cord-344478-5gp7v1uh	21	15	publication	publication	NN
cord-344478-5gp7v1uh	21	16	,	,	,
cord-344478-5gp7v1uh	21	17	the	the	DT
cord-344478-5gp7v1uh	21	18	generalizability	generalizability	NN
cord-344478-5gp7v1uh	21	19	benefit	benefit	NN
cord-344478-5gp7v1uh	21	20	of	of	IN
cord-344478-5gp7v1uh	21	21	including	include	VBG
cord-344478-5gp7v1uh	21	22	25	25	CD
cord-344478-5gp7v1uh	21	23	hospitals	hospital	NNS
cord-344478-5gp7v1uh	21	24	into	into	IN
cord-344478-5gp7v1uh	21	25	the	the	DT
cord-344478-5gp7v1uh	21	26	cohort	cohort	NN
cord-344478-5gp7v1uh	21	27	with	with	IN
cord-344478-5gp7v1uh	21	28	differing	differ	VBG
cord-344478-5gp7v1uh	21	29	therapeutic	therapeutic	JJ
cord-344478-5gp7v1uh	21	30	protocols	protocol	NNS
cord-344478-5gp7v1uh	21	31	and	and	CC
cord-344478-5gp7v1uh	21	32	approaches	approach	NNS
cord-344478-5gp7v1uh	21	33	,	,	,
cord-344478-5gp7v1uh	21	34	and	and	CC
cord-344478-5gp7v1uh	21	35	it	-PRON-	PRP
cord-344478-5gp7v1uh	21	36	misrepresents	misrepresent	VBZ
cord-344478-5gp7v1uh	21	37	the	the	DT
cord-344478-5gp7v1uh	21	38	fatality	fatality	NN
cord-344478-5gp7v1uh	21	39	rate	rate	NN
cord-344478-5gp7v1uh	21	40	in	in	IN
cord-344478-5gp7v1uh	21	41	our	-PRON-	PRP$
cord-344478-5gp7v1uh	21	42	study	study	NN
cord-344478-5gp7v1uh	21	43	.	.	.
cord-344478-5gp7v1uh	22	1	We	-PRON-	PRP
cord-344478-5gp7v1uh	22	2	reported	report	VBD
cord-344478-5gp7v1uh	22	3	20.3	20.3	CD
cord-344478-5gp7v1uh	22	4	%	%	NN
cord-344478-5gp7v1uh	22	5	(	(	-LRB-
cord-344478-5gp7v1uh	22	6	95	95	CD
cord-344478-5gp7v1uh	22	7	%	%	NN
cord-344478-5gp7v1uh	22	8	CI	ci	NN
cord-344478-5gp7v1uh	22	9	:	:	:
cord-344478-5gp7v1uh	22	10	[	[	-LRB-
cord-344478-5gp7v1uh	22	11	18	18	CD
cord-344478-5gp7v1uh	22	12	.	.	.
cord-344478-5gp7v1uh	22	13	.4	.4	CD
cord-344478-5gp7v1uh	22	14	%	%	NN
cord-344478-5gp7v1uh	22	15	]	]	-RRB-
cord-344478-5gp7v1uh	22	16	)	)	-RRB-
cord-344478-5gp7v1uh	22	17	fatality	fatality	NN
cord-344478-5gp7v1uh	22	18	from	from	IN
cord-344478-5gp7v1uh	22	19	292	292	CD
cord-344478-5gp7v1uh	22	20	deaths	death	NNS
cord-344478-5gp7v1uh	22	21	in	in	IN
cord-344478-5gp7v1uh	22	22	1,438	1,438	CD
cord-344478-5gp7v1uh	22	23	patients	patient	NNS
cord-344478-5gp7v1uh	22	24	,	,	,
cord-344478-5gp7v1uh	22	25	whereas	whereas	IN
cord-344478-5gp7v1uh	22	26	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	22	27	et	et	NNP
cord-344478-5gp7v1uh	22	28	al	al	NNP
cord-344478-5gp7v1uh	22	29	report	report	NN
cord-344478-5gp7v1uh	22	30	18.1	18.1	CD
cord-344478-5gp7v1uh	22	31	%	%	NN
cord-344478-5gp7v1uh	22	32	from	from	IN
cord-344478-5gp7v1uh	22	33	460	460	CD
cord-344478-5gp7v1uh	22	34	deaths	death	NNS
cord-344478-5gp7v1uh	22	35	in	in	IN
cord-344478-5gp7v1uh	22	36	2,541	2,541	CD
cord-344478-5gp7v1uh	22	37	patients	patient	NNS
cord-344478-5gp7v1uh	22	38	in	in	IN
cord-344478-5gp7v1uh	22	39	a	a	DT
cord-344478-5gp7v1uh	22	40	later	later	JJ
cord-344478-5gp7v1uh	22	41	era	era	NN
cord-344478-5gp7v1uh	22	42	of	of	IN
cord-344478-5gp7v1uh	22	43	the	the	DT
cord-344478-5gp7v1uh	22	44	COVID-19	covid-19	JJ
cord-344478-5gp7v1uh	22	45	epidemic	epidemic	NN
cord-344478-5gp7v1uh	22	46	.	.	.
cord-344478-5gp7v1uh	23	1	We	-PRON-	PRP
cord-344478-5gp7v1uh	23	2	fail	fail	VBP
cord-344478-5gp7v1uh	23	3	to	to	TO
cord-344478-5gp7v1uh	23	4	find	find	VB
cord-344478-5gp7v1uh	23	5	a	a	DT
cord-344478-5gp7v1uh	23	6	difference	difference	NN
cord-344478-5gp7v1uh	23	7	between	between	IN
cord-344478-5gp7v1uh	23	8	these	these	DT
cord-344478-5gp7v1uh	23	9	studies	study	NNS
cord-344478-5gp7v1uh	23	10	'	'	POS
cord-344478-5gp7v1uh	23	11	fatality	fatality	NN
cord-344478-5gp7v1uh	23	12	rates	rate	NNS
cord-344478-5gp7v1uh	24	1	both	both	DT
cord-344478-5gp7v1uh	24	2	practically	practically	RB
cord-344478-5gp7v1uh	24	3	and	and	CC
cord-344478-5gp7v1uh	24	4	statistically	statistically	RB
cord-344478-5gp7v1uh	24	5	(	(	-LRB-
cord-344478-5gp7v1uh	24	6			``
cord-344478-5gp7v1uh	24	7	2	2	CD
cord-344478-5gp7v1uh	24	8	df=1	df=1	NNS
cord-344478-5gp7v1uh	24	9	test	test	NN
cord-344478-5gp7v1uh	24	10	p=0.09	p=0.09	NN
cord-344478-5gp7v1uh	24	11	)	)	-RRB-
cord-344478-5gp7v1uh	24	12	.	.	.
cord-344478-5gp7v1uh	25	1	These	these	DT
cord-344478-5gp7v1uh	25	2	erroneous	erroneous	JJ
cord-344478-5gp7v1uh	25	3	representations	representation	NNS
cord-344478-5gp7v1uh	25	4	of	of	IN
cord-344478-5gp7v1uh	25	5	previous	previous	JJ
cord-344478-5gp7v1uh	25	6	work	work	NN
cord-344478-5gp7v1uh	25	7	should	should	MD
cord-344478-5gp7v1uh	25	8	be	be	VB
cord-344478-5gp7v1uh	25	9	clarified	clarify	VBN
cord-344478-5gp7v1uh	25	10	as	as	IN
cord-344478-5gp7v1uh	25	11	they	-PRON-	PRP
cord-344478-5gp7v1uh	25	12	have	have	VBP
cord-344478-5gp7v1uh	25	13	appeared	appear	VBN
cord-344478-5gp7v1uh	25	14	to	to	TO
cord-344478-5gp7v1uh	25	15	have	have	VB
cord-344478-5gp7v1uh	25	16	led	lead	VBN
cord-344478-5gp7v1uh	25	17	to	to	IN
cord-344478-5gp7v1uh	25	18	confusion	confusion	NN
cord-344478-5gp7v1uh	25	19	in	in	IN
cord-344478-5gp7v1uh	25	20	subsequent	subsequent	JJ
cord-344478-5gp7v1uh	25	21	characterizations	characterization	NNS
cord-344478-5gp7v1uh	25	22	of	of	IN
cord-344478-5gp7v1uh	25	23	the	the	DT
cord-344478-5gp7v1uh	25	24	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	25	25	et	et	NNP
cord-344478-5gp7v1uh	25	26	al	al	NNP
cord-344478-5gp7v1uh	25	27	paper	paper	NN
cord-344478-5gp7v1uh	25	28	relative	relative	NN
cord-344478-5gp7v1uh	25	29	to	to	IN
cord-344478-5gp7v1uh	25	30	our	-PRON-	PRP$
cord-344478-5gp7v1uh	25	31	study	study	NN
cord-344478-5gp7v1uh	25	32	[	[	-LRB-
cord-344478-5gp7v1uh	25	33	5	5	CD
cord-344478-5gp7v1uh	25	34	,	,	,
cord-344478-5gp7v1uh	25	35	6	6	CD
cord-344478-5gp7v1uh	25	36	]	]	-RRB-
cord-344478-5gp7v1uh	25	37	.	.	.
cord-344478-5gp7v1uh	26	1	Arshad	Arshad	NNP
cord-344478-5gp7v1uh	26	2	et	et	NNP
cord-344478-5gp7v1uh	26	3	al	al	NNP
cord-344478-5gp7v1uh	26	4	study	study	NN
cord-344478-5gp7v1uh	26	5	[	[	-LRB-
cord-344478-5gp7v1uh	26	6	7	7	CD
cord-344478-5gp7v1uh	26	7	]	]	-RRB-
cord-344478-5gp7v1uh	26	8	.	.	.
cord-344478-5gp7v1uh	27	1	We	-PRON-	PRP
cord-344478-5gp7v1uh	27	2	underscore	underscore	VBP
cord-344478-5gp7v1uh	27	3	the	the	DT
cord-344478-5gp7v1uh	27	4	concerns	concern	NNS
cord-344478-5gp7v1uh	27	5	raised	raise	VBD
cord-344478-5gp7v1uh	27	6	that	that	DT
cord-344478-5gp7v1uh	27	7	bias	bias	NN
cord-344478-5gp7v1uh	27	8	may	may	MD
cord-344478-5gp7v1uh	27	9	have	have	VB
cord-344478-5gp7v1uh	27	10	been	be	VBN
cord-344478-5gp7v1uh	27	11	introduced	introduce	VBN
cord-344478-5gp7v1uh	27	12	into	into	IN
cord-344478-5gp7v1uh	27	13	the	the	DT
cord-344478-5gp7v1uh	27	14	inpatient	inpatient	JJ
cord-344478-5gp7v1uh	27	15	treatment	treatment	NN
cord-344478-5gp7v1uh	27	16	of	of	IN
cord-344478-5gp7v1uh	27	17	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	27	18	were	be	VBD
cord-344478-5gp7v1uh	27	19	stopped	stop	VBN
cord-344478-5gp7v1uh	27	20	early	early	RB
cord-344478-5gp7v1uh	27	21	due	due	IN
cord-344478-5gp7v1uh	27	22	to	to	IN
cord-344478-5gp7v1uh	27	23	lack	lack	NN
cord-344478-5gp7v1uh	27	24	of	of	IN
cord-344478-5gp7v1uh	27	25	efficacy	efficacy	NN
cord-344478-5gp7v1uh	27	26	[	[	-LRB-
cord-344478-5gp7v1uh	27	27	9	9	CD
cord-344478-5gp7v1uh	27	28	,	,	,
cord-344478-5gp7v1uh	27	29	10	10	CD
cord-344478-5gp7v1uh	27	30	]	]	-RRB-
cord-344478-5gp7v1uh	27	31	.	.	.
cord-344478-5gp7v1uh	28	1	On	on	IN
cord-344478-5gp7v1uh	28	2	July	July	NNP
cord-344478-5gp7v1uh	28	3	4	4	CD
cord-344478-5gp7v1uh	28	4	,	,	,
cord-344478-5gp7v1uh	28	5	the	the	DT
cord-344478-5gp7v1uh	28	6	WHO	who	WP
cord-344478-5gp7v1uh	28	7	similarly	similarly	RB
cord-344478-5gp7v1uh	28	8	halted	halt	VBD
cord-344478-5gp7v1uh	28	9	the	the	DT
cord-344478-5gp7v1uh	28	10	hydroxycholorquine	hydroxycholorquine	NN
cord-344478-5gp7v1uh	28	11	arm	arm	NN
cord-344478-5gp7v1uh	28	12	of	of	IN
cord-344478-5gp7v1uh	28	13	their	-PRON-	PRP$
cord-344478-5gp7v1uh	28	14	Solidarity	Solidarity	NNP
cord-344478-5gp7v1uh	28	15	Trial	Trial	NNP
cord-344478-5gp7v1uh	28	16	[	[	-LRB-
cord-344478-5gp7v1uh	28	17	11	11	CD
cord-344478-5gp7v1uh	28	18	]	]	-RRB-
cord-344478-5gp7v1uh	28	19	.	.	.
cord-344478-5gp7v1uh	29	1	Evidence	evidence	NN
cord-344478-5gp7v1uh	29	2	from	from	IN
cord-344478-5gp7v1uh	29	3	RECOVERY	recovery	NN
cord-344478-5gp7v1uh	29	4	was	be	VBD
cord-344478-5gp7v1uh	29	5	a	a	DT
cord-344478-5gp7v1uh	29	6	key	key	JJ
cord-344478-5gp7v1uh	29	7	factor	factor	NN
cord-344478-5gp7v1uh	29	8	weighed	weigh	VBD
cord-344478-5gp7v1uh	29	9	in	in	IN
cord-344478-5gp7v1uh	29	10	the	the	DT
cord-344478-5gp7v1uh	29	11	US	US	NNP
cord-344478-5gp7v1uh	29	12	Food	Food	NNP
cord-344478-5gp7v1uh	29	13	and	and	CC
cord-344478-5gp7v1uh	29	14	Drug	Drug	NNP
cord-344478-5gp7v1uh	29	15	Administration	Administration	NNP
cord-344478-5gp7v1uh	29	16	's	's	POS
cord-344478-5gp7v1uh	29	17	(	(	-LRB-
cord-344478-5gp7v1uh	29	18	FDA	FDA	NNP
cord-344478-5gp7v1uh	29	19	)	)	-RRB-
cord-344478-5gp7v1uh	29	20	June	June	NNP
cord-344478-5gp7v1uh	29	21	15	15	CD
cord-344478-5gp7v1uh	29	22	decision	decision	NN
cord-344478-5gp7v1uh	29	23	to	to	TO
cord-344478-5gp7v1uh	29	24	revoke	revoke	VB
cord-344478-5gp7v1uh	29	25	hydroxychloroquine	hydroxychloroquine	NNP
cord-344478-5gp7v1uh	29	26	's	's	POS
cord-344478-5gp7v1uh	29	27	Emergency	Emergency	NNP
cord-344478-5gp7v1uh	29	28	Use	Use	NNP
cord-344478-5gp7v1uh	29	29	Authorization	Authorization	NNP
cord-344478-5gp7v1uh	29	30	(	(	-LRB-
cord-344478-5gp7v1uh	29	31	EUA	EUA	NNP
cord-344478-5gp7v1uh	29	32	)	)	-RRB-
cord-344478-5gp7v1uh	29	33	for	for	IN
cord-344478-5gp7v1uh	29	34	COVID-19	covid-19	JJ
cord-344478-5gp7v1uh	29	35	treatment	treatment	NN
cord-344478-5gp7v1uh	29	36	[	[	-LRB-
cord-344478-5gp7v1uh	29	37	12	12	CD
cord-344478-5gp7v1uh	29	38	]	]	-RRB-
cord-344478-5gp7v1uh	29	39	.	.	.
cord-344478-5gp7v1uh	30	1	We	-PRON-	PRP
cord-344478-5gp7v1uh	30	2	appreciate	appreciate	VBP
cord-344478-5gp7v1uh	30	3	the	the	DT
cord-344478-5gp7v1uh	30	4	opportunity	opportunity	NN
cord-344478-5gp7v1uh	30	5	to	to	TO
cord-344478-5gp7v1uh	30	6	clarify	clarify	VB
cord-344478-5gp7v1uh	30	7	the	the	DT
cord-344478-5gp7v1uh	30	8	record	record	NN
cord-344478-5gp7v1uh	30	9	regarding	regard	VBG
cord-344478-5gp7v1uh	30	10	our	-PRON-	PRP$
cord-344478-5gp7v1uh	30	11	study	study	NN
cord-344478-5gp7v1uh	30	12	as	as	IN
cord-344478-5gp7v1uh	30	13	described	describe	VBN
cord-344478-5gp7v1uh	30	14	by	by	IN
cord-344478-5gp7v1uh	30	15	 	 	_SP
cord-344478-5gp7v1uh	30	16	Treatment	Treatment	NNP
cord-344478-5gp7v1uh	30	17	with	with	IN
cord-344478-5gp7v1uh	30	18	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	30	19	,	,	,
cord-344478-5gp7v1uh	30	20	Azithromycin	Azithromycin	NNP
cord-344478-5gp7v1uh	30	21	,	,	,
cord-344478-5gp7v1uh	30	22	and	and	CC
cord-344478-5gp7v1uh	30	23	Combination	combination	NN
cord-344478-5gp7v1uh	30	24	in	in	IN
cord-344478-5gp7v1uh	30	25	Patients	patient	NNS
cord-344478-5gp7v1uh	30	26	Hospitalized	hospitalize	VBN
cord-344478-5gp7v1uh	30	27	with	with	IN
cord-344478-5gp7v1uh	30	28	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	30	29	Swinging	swinge	VBG
cord-344478-5gp7v1uh	30	30	the	the	DT
cord-344478-5gp7v1uh	30	31	pendulum	pendulum	NN
cord-344478-5gp7v1uh	30	32	:	:	:
cord-344478-5gp7v1uh	30	33	lessons	lesson	NNS
cord-344478-5gp7v1uh	30	34	learned	learn	VBN
cord-344478-5gp7v1uh	30	35	from	from	IN
cord-344478-5gp7v1uh	30	36	public	public	JJ
cord-344478-5gp7v1uh	30	37	discourse	discourse	NN
cord-344478-5gp7v1uh	30	38	concerning	concern	VBG
cord-344478-5gp7v1uh	30	39	hydroxychloroquine	hydroxychloroquine	NNP
cord-344478-5gp7v1uh	30	40	and	and	CC
cord-344478-5gp7v1uh	30	41	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	30	42	.	.	.
cord-344478-5gp7v1uh	31	1	Expert	expert	NN
cord-344478-5gp7v1uh	31	2	review	review	NN
cord-344478-5gp7v1uh	31	3	of	of	IN
cord-344478-5gp7v1uh	31	4	clinical	clinical	JJ
cord-344478-5gp7v1uh	31	5	immunology	immunology	NN
cord-344478-5gp7v1uh	31	6	Observational	Observational	NNP
cord-344478-5gp7v1uh	31	7	Study	Study	NNP
cord-344478-5gp7v1uh	31	8	of	of	IN
cord-344478-5gp7v1uh	31	9	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	31	10	in	in	IN
cord-344478-5gp7v1uh	31	11	Hospitalized	Hospitalized	NNP
cord-344478-5gp7v1uh	31	12	Patients	Patients	NNP
cord-344478-5gp7v1uh	31	13	with	with	IN
cord-344478-5gp7v1uh	31	14	Covid-19	Covid-19	NNP
cord-344478-5gp7v1uh	31	15	Association	Association	NNP
cord-344478-5gp7v1uh	31	16	of	of	IN
cord-344478-5gp7v1uh	31	17	Treatment	Treatment	NNP
cord-344478-5gp7v1uh	31	18	With	with	IN
cord-344478-5gp7v1uh	31	19	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	31	20	or	or	CC
cord-344478-5gp7v1uh	31	21	Azithromycin	Azithromycin	NNP
cord-344478-5gp7v1uh	31	22	With	with	IN
cord-344478-5gp7v1uh	31	23	In	in	IN
cord-344478-5gp7v1uh	31	24	-	-	HYPH
cord-344478-5gp7v1uh	31	25	Hospital	hospital	NN
cord-344478-5gp7v1uh	31	26	Mortality	mortality	NN
cord-344478-5gp7v1uh	31	27	in	in	IN
cord-344478-5gp7v1uh	31	28	Patients	patient	NNS
cord-344478-5gp7v1uh	31	29	With	with	IN
cord-344478-5gp7v1uh	31	30	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	31	31	in	in	IN
cord-344478-5gp7v1uh	31	32	Treatment	Treatment	NNP
cord-344478-5gp7v1uh	31	33	with	with	IN
cord-344478-5gp7v1uh	31	34	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	31	35	Cut	Cut	NNP
cord-344478-5gp7v1uh	31	36	Death	death	NN
cord-344478-5gp7v1uh	31	37	Rate	Rate	NNP
cord-344478-5gp7v1uh	31	38	Significantly	significantly	RB
cord-344478-5gp7v1uh	31	39	in	in	IN
cord-344478-5gp7v1uh	31	40	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	31	41	Patients	Patients	NNPS
cord-344478-5gp7v1uh	31	42	,	,	,
cord-344478-5gp7v1uh	31	43	Henry	Henry	NNP
cord-344478-5gp7v1uh	31	44	Ford	Ford	NNP
cord-344478-5gp7v1uh	31	45	Health	Health	NNP
cord-344478-5gp7v1uh	31	46	System	System	NNP
cord-344478-5gp7v1uh	31	47	Study	Study	NNP
cord-344478-5gp7v1uh	31	48	Shows	show	VBZ
cord-344478-5gp7v1uh	31	49	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	31	50	saved	save	VBD
cord-344478-5gp7v1uh	31	51	lives	life	NNS
cord-344478-5gp7v1uh	31	52	among	among	IN
cord-344478-5gp7v1uh	31	53	coronavirus	coronavirus	NN
cord-344478-5gp7v1uh	31	54	patients	patient	NNS
cord-344478-5gp7v1uh	31	55	2020	2020	CD
cord-344478-5gp7v1uh	32	1	An	an	DT
cord-344478-5gp7v1uh	32	2	Observational	Observational	NNP
cord-344478-5gp7v1uh	32	3	Cohort	Cohort	NNP
cord-344478-5gp7v1uh	32	4	Study	Study	NNP
cord-344478-5gp7v1uh	32	5	of	of	IN
cord-344478-5gp7v1uh	32	6	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-344478-5gp7v1uh	32	7	and	and	CC
cord-344478-5gp7v1uh	32	8	Azithromycin	Azithromycin	NNP
cord-344478-5gp7v1uh	32	9	for	for	IN
cord-344478-5gp7v1uh	32	10	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	32	11	:	:	:
cord-344478-5gp7v1uh	33	1	(	(	-LRB-
cord-344478-5gp7v1uh	33	2	Can’t	Can’t	NNP
cord-344478-5gp7v1uh	33	3	Get	get	VB
cord-344478-5gp7v1uh	33	4	No	no	DT
cord-344478-5gp7v1uh	33	5	)	)	-RRB-
cord-344478-5gp7v1uh	33	6	Satisfaction	satisfaction	NN
cord-344478-5gp7v1uh	33	7	Effect	effect	NN
cord-344478-5gp7v1uh	33	8	of	of	IN
cord-344478-5gp7v1uh	33	9	Dexamethasone	Dexamethasone	NNP
cord-344478-5gp7v1uh	33	10	in	in	IN
cord-344478-5gp7v1uh	33	11	Hospitalized	Hospitalized	NNP
cord-344478-5gp7v1uh	33	12	Patients	Patients	NNP
cord-344478-5gp7v1uh	33	13	with	with	IN
cord-344478-5gp7v1uh	33	14	COVID-19	covid-19	CD
cord-344478-5gp7v1uh	33	15	:	:	:
cord-344478-5gp7v1uh	33	16	Preliminary	Preliminary	NNP
cord-344478-5gp7v1uh	33	17	Report	Report	NNP
cord-344478-5gp7v1uh	34	1	No	no	DT
cord-344478-5gp7v1uh	34	2	clinical	clinical	JJ
cord-344478-5gp7v1uh	34	3	benefit	benefit	NN
cord-344478-5gp7v1uh	34	4	from	from	IN
cord-344478-5gp7v1uh	34	5	use	use	NN
cord-344478-5gp7v1uh	34	6	of	of	IN
cord-344478-5gp7v1uh	34	7	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	34	8	in	in	IN
cord-344478-5gp7v1uh	34	9	hospitalised	hospitalise	VBN
cord-344478-5gp7v1uh	34	10	patients	patient	NNS
cord-344478-5gp7v1uh	34	11	with	with	IN
cord-344478-5gp7v1uh	35	1	COVID-19	COVID-19	NNP
cord-344478-5gp7v1uh	35	2	2020	2020	CD
cord-344478-5gp7v1uh	35	3	NIH	NIH	NNP
cord-344478-5gp7v1uh	35	4	halts	halt	VBZ
cord-344478-5gp7v1uh	35	5	clinical	clinical	JJ
cord-344478-5gp7v1uh	35	6	trial	trial	NN
cord-344478-5gp7v1uh	35	7	of	of	IN
cord-344478-5gp7v1uh	35	8	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	35	9	:	:	:
cord-344478-5gp7v1uh	36	1	Study	study	NN
cord-344478-5gp7v1uh	36	2	shows	show	VBZ
cord-344478-5gp7v1uh	36	3	treatment	treatment	NN
cord-344478-5gp7v1uh	36	4	does	do	VBZ
cord-344478-5gp7v1uh	36	5	no	no	DT
cord-344478-5gp7v1uh	36	6	harm	harm	NN
cord-344478-5gp7v1uh	36	7	,	,	,
cord-344478-5gp7v1uh	36	8	but	but	CC
cord-344478-5gp7v1uh	36	9	provides	provide	VBZ
cord-344478-5gp7v1uh	36	10	no	no	DT
cord-344478-5gp7v1uh	36	11	benefit	benefit	NN
cord-344478-5gp7v1uh	36	12	2020	2020	CD
cord-344478-5gp7v1uh	36	13	WHO	who	WP
cord-344478-5gp7v1uh	36	14	.	.	.
cord-344478-5gp7v1uh	37	1	WHO	who	WP
cord-344478-5gp7v1uh	37	2	discontinues	discontinue	VBZ
cord-344478-5gp7v1uh	37	3	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	37	4	and	and	CC
cord-344478-5gp7v1uh	37	5	lopinavir	lopinavir	NNP
cord-344478-5gp7v1uh	37	6	/	/	SYM
cord-344478-5gp7v1uh	37	7	ritonavir	ritonavir	NNP
cord-344478-5gp7v1uh	37	8	treatment	treatment	NN
cord-344478-5gp7v1uh	37	9	arms	arm	NNS
cord-344478-5gp7v1uh	37	10	for	for	IN
cord-344478-5gp7v1uh	37	11	COVID-19	covid-19	CD
cord-344478-5gp7v1uh	37	12	2020	2020	CD
cord-344478-5gp7v1uh	37	13	Letter	Letter	NNP
cord-344478-5gp7v1uh	37	14	revoking	revoke	VBG
cord-344478-5gp7v1uh	37	15	EUA	EUA	NNP
cord-344478-5gp7v1uh	37	16	for	for	IN
cord-344478-5gp7v1uh	37	17	chloroquine	chloroquine	NN
cord-344478-5gp7v1uh	37	18	phosphate	phosphate	NN
cord-344478-5gp7v1uh	37	19	and	and	CC
cord-344478-5gp7v1uh	37	20	hydroxychloroquine	hydroxychloroquine	NN
cord-344478-5gp7v1uh	37	21	sulfate	sulfate	NN
cord-344478-5gp7v1uh	37	22	2020	2020	CD